GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ganga Pharmaceuticals Ltd (BOM:539680) » Definitions » Days Sales Outstanding

Ganga Pharmaceuticals (BOM:539680) Days Sales Outstanding : 131.41 (As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is Ganga Pharmaceuticals Days Sales Outstanding?

Ganga Pharmaceuticals's average Accounts Receivable for the six months ended in Mar. 2025 was ₹9.55 Mil. Ganga Pharmaceuticals's Revenue for the six months ended in Mar. 2025 was ₹13.26 Mil. Hence, Ganga Pharmaceuticals's Days Sales Outstanding for the six months ended in Mar. 2025 was 131.41.

The historical rank and industry rank for Ganga Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

BOM:539680' s Days Sales Outstanding Range Over the Past 10 Years
Min: 98.96   Med: 129.24   Max: 169.42
Current: 129.37

During the past 11 years, Ganga Pharmaceuticals's highest Days Sales Outstanding was 169.42. The lowest was 98.96. And the median was 129.24.

BOM:539680's Days Sales Outstanding is ranked worse than
83.39% of 957 companies
in the Drug Manufacturers industry
Industry Median: 72.09 vs BOM:539680: 129.37

Ganga Pharmaceuticals's Days Sales Outstanding increased from Mar. 2024 (122.49) to Mar. 2025 (131.41).


Ganga Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Ganga Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ganga Pharmaceuticals Days Sales Outstanding Chart

Ganga Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145.29 125.49 125.67 120.90 126.89

Ganga Pharmaceuticals Semi-Annual Data
Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 144.14 129.16 122.49 133.77 131.41

Competitive Comparison of Ganga Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Ganga Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ganga Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ganga Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Ganga Pharmaceuticals's Days Sales Outstanding falls into.


;
;

Ganga Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Ganga Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Mar. 2025 is calculated as

Days Sales Outstanding (A: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Mar. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (9.232 + 9.106) / 2 ) / 26.374*365
=9.169 / 26.374*365
=126.89

Ganga Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding (Q: Mar. 2025 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Sep. 2024 ) + Accounts Receivable (A: Mar. 2025 )) / count ) / Revenue (A: Mar. 2025 )*Days in Period
=( (9.991 + 9.106) / 2 ) / 13.261*365 / 2
=9.5485 / 13.261*365 / 2
=131.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ganga Pharmaceuticals  (BOM:539680) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Ganga Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Ganga Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Ganga Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
Dhanvantri Marg, Gangatat, Gopcharpada, Near Digi 1 Electronic Showroom, Virar (East), Palghar, MH, IND, 401305
Ganga Pharmaceuticals Ltd is an India based producer of ayurvedic medicines. It is engaged in the business of manufacturing and trading in ayurvedic pharmaceuticals and allied products. The company is also involved in the marketing and distribution of bulk ayurvedic medicines. The firm offers ayurvedic medicines for acidity, anti-dandruff, anti-oxidants, dental care, diarrhea, iron tonic, liver disorder, weight management, kidney stone, joint pains, liver disorder and others.

Ganga Pharmaceuticals Headlines

No Headlines